CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


ImmunfluorescenceWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (4)


Name (Synonyms) Correlation
D003141 Communicable Diseases NIH 0.09
D007239 Infection NIH 0.06
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Prospective Assay for SARS-CoV-2 Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method

Prospective assay for SARS-CoV-2 antibody detection indirectly by immunofluorescence: SARS-CoV2 IIF method

NCT04429620 Sars-CoV2 Diagnostic Test: Immunfluorescence

Primary Outcomes

Description: Sensitivity of the method by SARS-CoV2 ELISA compared

Measure: Sensitivity of the method by SARS-CoV2 ELISA compared

Time: 8 months

Secondary Outcomes

Description: Detectability of the antibodies IgA type against SARS-CoV2 virus in the early stages of the disease.

Measure: Detectability of the antibodies IgA type against SARS-CoV2 virus

Time: 8 months


No related HPO nodes (Using clinical trials)